During an appearance in Cincinnati, Ohio, to promote his infrastructure plan, President Donald Trump told the press that the Patient Protection and Affordable Care Act (PPACA) is in a “death spiral” and must be reformed soon, according to Reuters. His comments came one day after insurer Anthem Inc.

Treatments for patients with rheumatoid arthritis (RA), a disabling disease affecting approximately 1.5 million Americans, can have serious adverse effects, so doctors and patients were excited when tocilizumab (Actemra, Genentech) reached the U.S. market in 2010.

Patients notched a win over the pharmaceutical industry on June 5 when the Nevada Legislature revived a bill requiring insulin makers to disclose the profits they make on the life-sustaining drug, according to Kaiser Health News (KHN). In a few other states, bills addressing drug prices have stalled.

Teamwork and vigilance are key components of minimizing claims denials at health systems, hospitals, and physician practices, according to two finance executives who participated in a recent HealthLeaders Media Roundtable event. Their remarks were posted on the HealthLeaders Media website

President Donald Trump has decided to keep Francis Collins as head of the National Institutes of Health (NIH). That may be more of a curse than a blessing for Collins given that the president has also proposed slashing the agency’s budget by billions of dollars, according to a report posted on the FierceBiotech website.

The Senate Committee on the Budget has ruled that the American Health Care Act passed on May 4 by the House of Representatives, providing for the repeal and replacement of the Patient Protection and Affordable Care Act (PPACA), complies with the Senate reconciliation process.

A new analysis from the Centers for Disease Control and Prevention (CDC) has found that among the 21 U.S. jurisdictions studied, 76% reported health care-associated cases of Legionnaires’ disease––a concerning finding, the agency says, since Legionnaires’ disease acquired from health care facilities can be particularly severe.

A new study from Queen’s University in Ontario, Canada, has found that the pricing of cancer drugs appears to have no relationship to their effectiveness. The investigation also found that the most-expensive drugs were not the most beneficial.

The World Health Organization (WHO) has published a new classification of antibiotics aimed at fighting drug resistance, according to a Reuters report. The agency recommends penicillin-type drugs as the first line of defense and others only for use when absolutely necessary.

As millions of Americans struggle to pay their medical bills and worry that they might lose their insurance coverage if the Patient Protection and Affordable Care Act is repealed, many of America’s wealthiest citizens receive five-star treatment from doctors and hospitals if they are willing to fork over a five-figure annual fee, according to an article i

Senate Republicans may have too many cooks in the kitchen when it comes to health care, and it’s complicating their efforts to draft a bill to dismantle the Patient Protection and Affordable Care Act (PPACA), according to The Hill.

In what seems like the plot from a bad horror movie, officials at a Philadelphia-based company called Bioquark have announced that they are close to starting a clinical trial to determine whether a series of procedures administered to clinically dead people can bring them back to life, according to an article posted on the STAT website.

In a new phase 3 study, alectinib (Alecensa, Roche) significantly reduced the risk of disease worsening or death (progression-free survival [PFS]) by more than half (53%) compared with crizotinib (Xalkori, Pfizer) when administered as first-line treatment in patients with anaplastic lymphoma kinase (ALK)-positive advanced non–small-cell lung cancer (NSCLC

Pharma giant Pfizer has raised the U.S. prices of 91 drugs by approximately 20% so far this year, according to an article in the Washington Examiner. The price hikes came as the pharmaceutical industry faces Congressional scrutiny for its drug-pricing policies.

A long-awaited report by a federal task force has identified key cybersecurity vulnerabilities in health care and has emphasized the importance of collaboration among all stakeholders to close those gaps, according to an article posted on the Fierce Healthcare website.